Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
In July, Wabtec Corporation (WAB - Snapshot Report) reported record quarterly earnings and raised full year guidance. Will this Zacks #1 Rank (strong buy) keep it going in the face of a global slowdown?
Wabtec manufactures locomotives and a broad range of products for locomotives, freight cars and passenger transit vehicles. It also offers aftermarket services worldwide.
The company has two components. Westinghouse Air Brake was founded in 1869 by George Westinghouse after he created the first straight air brake system which revolutionized passenger train travel in the 1870s.
MotivePower Industries began building locomotives in the early 1970s. The two companies merged in 1999 to form Wabtec.
Building Locomotives for Central Florida and Seattle
On Sep 8, Wabtec announced its subsidiary MotivePower had signed contracts to build locomotives for commuter rail projects in Central Florida and Seattle for $30 million.
It is building 7 locomotives for the Central Florida project and 3 locomotives for the Seattle project. The locomotives are expected to be delivered in 2012 and 2013.
Best Quarter Ever in Q2
On July 26, Wabtec reported a record quarterly result which surprised on the Zacks Consensus for the 8th quarter in a row. Earnings per share were 94 cents compared to the Zacks Consensus of 85 cents.
Sales jumped 28% to a record $479 million due to strong growth in the Freight Group. It was the second quarter in a row that the company had record sales.
The backlog was also at a record high of $1.51 billion, up 40% from the end of 2010.
Raised Full Year Guidance
Given the record backlog and strong demand in both the first and second quarters, Wabtec raised its full year guidance to a range of $3.45 to $3.55 per share from its April guidance of $3.20 to $3.30 per share.
Revenue is expected to grow 20% for the year.
Zacks Consensus Estimates Rise
With another beat and with a higher revision to the earnings guidance, it's not surprising that analysts have been raising full year estimates.
The 2011 Zacks Consensus jumped to $3.57 from $3.39 per share in the last 60 days. That is above the company's guidance range. But with two record quarters in a row and a record backlog, it makes sense that they may do it again in the third or fourth quarter.
That is earnings growth of 39.4% which isn't too shabby for a company that was founded 142 years ago.
Shares Retreat
Like most of the stock market, Wabtec shares have sold off in recent weeks making it an even more attractive buying opportunity.
A Value Stock
Wabtec has a forward P/E of 14.9 which just puts it within the limit I use for value stocks, which is under 15.0. So it's not dirt cheap by that metric.
But it still have value fundamentals including a price-to-book ratio of 2.5. A P/B under 3.0 usually indicates value.
The company has other strong fundamentals including a return on equity of 15.7%. With its double digit earnings growth it also sports a PEG ratio of 0.9 which is right on the cusp of indicating the company is undervalued as well. Value investors look for a PEG under 1.0.
Shareholders also are rewarded with a dividend, but with a yield of just 0.2%, it's not the reason you're buying the company.
Wabtec is cashing in on worldwide railroad growth 142 years after it burst on the scene. Sometimes, the more things change, the more they stay the same.
Wabtec is scheduled to report third quarter results on Oct 26. We'll see if it can make it 3 record quarters in a row.
Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor of the Turnaround Trader and Insider Trader services. You can follow her at twitter.com/traceyryniec.
Get the full Snapshot Report on WAB - FREE